
Delivering Innovation to the EyeTM
Focused on developing and commercializing innovative ophthalmic products and technologies for serious ophthalmic diseases
About EyePoint
Words of Wisdom, Inspiration, and Hope from Top Ophthalmologists
Latest EyePoint News
- EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
- EyePoint Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
- EyePoint Pharmaceuticals Announces Closing of $115 Million Public Offering of Common Stock
- EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
- EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock